Pharmacovigilance & Clinical Trials

The Pharmacovigilance department has three Units:

  1. Public health unit   
  2. Clinical practice unit     
  3. Clinical trials unit
Its functions include:
  • Communicate safety information to health practitioners and  the general public through newsletters, the electronic and print media
  • Distribute adverse drug reaction (ADR) forms to all health facilities nationwide
  • Confirm receipt of Adverse drug reaction( ADR) including Adverse event following immunization (AEFI) reports and give feedback to reporters, participating institutions and other key stakeholders
  • Commit  ADR reports to WHO – UMC vigiflow database
  • Evaluation of clinical data for registration of new products
  • Collaboration with pharmaceutical manufacturers concerning the safety of marketed products
  • Conduct hospital inspections 
  • Conduct Pharmacovigilance Inspections
Contact the department through this email: